259 related articles for article (PubMed ID: 24198286)
1. A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis.
Dunn LL; Simpson PJ; Prosser HC; Lecce L; Yuen GS; Buckle A; Sieveking DP; Vanags LZ; Lim PR; Chow RW; Lam YT; Clayton Z; Bao S; Davies MJ; Stadler N; Celermajer DS; Stocker R; Bursill CA; Cooke JP; Ng MK
Diabetes; 2014 Feb; 63(2):675-87. PubMed ID: 24198286
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte-specific Txnip C247S mutation improves left ventricular functional reserve in streptozotocin-induced diabetic mice.
Mukai N; Nakayama Y; Abdali SA; Yoshioka J
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H259-H274. PubMed ID: 34085839
[TBL] [Abstract][Full Text] [Related]
3. Thioredoxin1 Inactivation Mediates the Impairment of Ischemia-Induced Angiogenesis and Further Injury in Diabetic Myocardium.
Hou R; Shen M; Wang R; Liu H; Gao C; Xu J; Tao L; Yin Z; Yin T
J Vasc Res; 2020; 57(2):76-85. PubMed ID: 31968349
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
5. Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation.
Domingues A; Boisson-Vidal C; Marquet de Rouge P; Dizier B; Sadoine J; Mignon V; Vessières E; Henrion D; Escriou V; Bigey P; Chaussain C; Smadja DM; Nivet-Antoine V
Angiogenesis; 2020 May; 23(2):249-264. PubMed ID: 31900750
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting Protein.
Yuan J; Tan JTM; Rajamani K; Solly EL; King EJ; Lecce L; Simpson PJL; Lam YT; Jenkins AJ; Bursill CA; Keech AC; Ng MKC
Diabetes; 2019 May; 68(5):1040-1053. PubMed ID: 30765336
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells.
Abdelsaid MA; Matragoon S; El-Remessy AB
Antioxid Redox Signal; 2013 Dec; 19(18):2199-212. PubMed ID: 23718729
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated Txnip-ROS-Wnt axis contributes to the impaired ischemic heart repair in diabetic mice.
Shen M; Bai D; Liu B; Lu X; Hou R; Zeng C; Li N; Fu Z; Li C; Tao L; Wang H; Yin T
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3735-3745. PubMed ID: 30261287
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin-Interacting Protein Inhibited Vascular Endothelial Cell-Induced HREC Angiogenesis Treatment of Diabetic Retinopathy.
Yan J; Deng J; Cheng F; Zhang T; Deng Y; Cai Y; Cong W
Appl Biochem Biotechnol; 2023 Feb; 195(2):1268-1283. PubMed ID: 36346561
[TBL] [Abstract][Full Text] [Related]
10. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.
Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370
[TBL] [Abstract][Full Text] [Related]
11. High beta-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice.
Masson E; Koren S; Razik F; Goldberg H; Kwan EP; Sheu L; Gaisano HY; Fantus IG
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1251-61. PubMed ID: 19223654
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.
Schulze PC; Yoshioka J; Takahashi T; He Z; King GL; Lee RT
J Biol Chem; 2004 Jul; 279(29):30369-74. PubMed ID: 15128745
[TBL] [Abstract][Full Text] [Related]
13. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
14. W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.
Li T; Lin GY; Zhong L; Zhou Y; Wang J; Zhu Y; Feng Y; Cai XQ; Liu Q; Nosjean O; Boutin JA; Renard P; Yang DH; Wang MW
Acta Pharmacol Sin; 2017 Jul; 38(7):1024-1037. PubMed ID: 28502980
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions.
Perrone L; Devi TS; Hosoya K; Terasaki T; Singh LP
J Cell Physiol; 2009 Oct; 221(1):262-72. PubMed ID: 19562690
[TBL] [Abstract][Full Text] [Related]
16. A central role for nicotinic cholinergic regulation of growth factor-induced endothelial cell migration.
Ng MK; Wu J; Chang E; Wang BY; Katzenberg-Clark R; Ishii-Watabe A; Cooke JP
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):106-12. PubMed ID: 17082486
[TBL] [Abstract][Full Text] [Related]
17. Endothelial thioredoxin interacting protein (TXNIP) modulates endothelium-dependent vasorelaxation in hyperglycemia.
Lam YT; Tan RP; Michael P; Yang N; Dunn LL; Cooke JP; Celermajer DS; Wise SG; Ng MKC
Microvasc Res; 2022 Sep; 143():104396. PubMed ID: 35644243
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production.
Chutkow WA; Patwari P; Yoshioka J; Lee RT
J Biol Chem; 2008 Jan; 283(4):2397-406. PubMed ID: 17998203
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin-interacting protein mediates TRX1 translocation to the plasma membrane in response to tumor necrosis factor-α: a key mechanism for vascular endothelial growth factor receptor-2 transactivation by reactive oxygen species.
World C; Spindel ON; Berk BC
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1890-7. PubMed ID: 21636804
[TBL] [Abstract][Full Text] [Related]
20. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression.
Zhang X; Zhao S; Yuan Q; Zhu L; Li F; Wang H; Kong D; Hao J
Cell Death Dis; 2021 Jun; 12(7):642. PubMed ID: 34162834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
